Video

Michael Bloch, MD, on Hypercholesterolemia: A Focus on PCSK9 Inhibitors

11/19/2019

In this video, Michael Bloch, MD, talks about his session at the Cardiometabolic Risk Summit 2019, which reviewed the latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, assessed current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and more.

Related Content

Lung Cancer
Lung Cancer
Could Certain NSCLC Patients Receive Combination Immunotherapy Without Chemotherapy?
09/13/2017
Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
09/13/2017
NAFLD
NAFLD
Arun Sanyal, MD on Metabolic-Pathway-Targeting Medication Options for NAFLD
07/02/2020
He talks about the treatment options that are available for treating nonalcoholic fatty liver disease via metabolic pathways. He recently spoke about this topic at the 21st Annual Harvard Nutrition and...
07/02/2020
Gastroenterology
Gastroenterology
Positioning Biologics and New Therapies for Crohn's Disease
07/30/2018
07/30/2018
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Antonio Anzueto, MD, on Steps to Understanding the Natural History of COPD
01/20/2021
In this video, Antonio Anzueto, MD, talks about the next steps in his research into treatment options for patients with symptomatic COPD who are at high risk of exacerbations.
01/20/2021
Gastroenterology
Gastroenterology
Best of DDW in Inflammatory Bowel Disease 2016 Webinar: An Update in Diagnosis, Prognosis, and Management of IBD
08/06/2018
08/06/2018